Services
We provide novel CRDMO services with a particular focus on mRNA vaccines and therapeutics as well as gene and cell therapy (GCT).
End-to-end
Plasmid, mRNA, LNP, and analytical QC are our four fundamental technology platforms. Our strong expertise and know-how aim to provide end-to-end solutions to our clients in the life cycle of mRNA therapeutics and GCT product development. We customize unique services and creative solutions to fit each client’s needs and timeline.
Key Services